Charlottesville, Va.-based UVA Health is expanding its Stay in the Game initiative, a targeted prostate cancer screening program aimed at boosting early detection among Black men. Speaking with Becker ...

Most men who are treated for prostate cancer according to modern guidelines have good survival rates and the majority of these men will die of causes ...

A new population-level study from Uppsala University has found that most men treated for non-metastatic prostate cancer ...

Novartis shares climb on strong Cosentyx sales, franchise growth, and a new malaria drug approval despite political risks.

During a live event, Jahan Aghalar, MD, discussed key NCCN-recommended oral therapies and landmark trials for metastatic ...

A local cancer survivor, Robert Dames, has released a new book titled "Cancer - What Now" to assist others in navigating the ...

ArteraAI Prostate analyzes digital pathology images of a prostate cancer biopsy slide to help clinicians predict long-term outcomes.

Real-world data suggest that Erleada may offer an advantage over other treatment options for patients with metastatic ...

Data from clinical trials have indicated that PSA is prognostic for outcomes, but little is known about real-world trends.

Nuclidium has raised 79 million Swiss francs ($99 million) as the Swiss and German biotech looks to continue the clinical ...

The National Cancer Institute faces severe budget cuts, staff exodus, and halted research, threatening decades of progress ...

Researchers investigated how Mindfulness-Based Cancer Recovery and Tai Chi/Qijong interventions could reduce distress levels in cancer survivors.